725- 31. CONFIDENTIAL CRUKD/17/003 Protocol Final 5.0 dated 08Jun2021 Page 66 of 72 EudraCT number: 2016 -002577 -35 Cancer Research UK 26. Reck, M., et al., Ipilimumab in combination with paclitaxel and carboplatin as first -line therapy in extensive- disease- small- cell lung cancer: results from a randomized, double- blind, multicenter phase 2 trial. Ann Oncol, 2013.